BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25280291)

  • 1. Re: defining variation in urinary oxalate in hyperoxaluric stone formers.
    Assimos DG
    J Urol; 2014 Jun; 191(6):1811-2. PubMed ID: 25280291
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxalate status in stone-formers. Two distinct hyperoxaluric entities.
    Hatch M
    Urol Res; 1993 Jan; 21(1):55-9. PubMed ID: 8456539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining variation in urinary oxalate in hyperoxaluric stone formers.
    Antonelli JA; Langman CB; Odom C; Poindexter J; Huet B; Pearle MS
    J Endourol; 2013 Dec; 27(12):1530-4. PubMed ID: 24147733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoxaluria in idiopathic calcium oxalate nephrolithiasis.
    Yendt ER
    Md Med J; 1988 Nov; 37(11):857-60. PubMed ID: 3185157
    [No Abstract]   [Full Text] [Related]  

  • 7. The variability and dietary dependence of urinary oxalate excretion in recurrent calcium stone formers.
    Brown JM; Stratmann G; Cowley DM; Mottram BM; Chalmers AH
    Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():385-90. PubMed ID: 3662388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral calcium supplement decreases urinary oxalate excretion in patients with enteric hyperoxaluria.
    Takei K; Ito H; Masai M; Kotake T
    Urol Int; 1998; 61(3):192-5. PubMed ID: 9933846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E; Albert A; Ponnusamy S; Mishra SR; Vignesh AG; Sivakumar SM; Sivasamy G; Sadasivam SG
    Microbiol Res; 2018 Oct; 215():65-75. PubMed ID: 30172310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.
    Kaelin A; Casez JP; Jaeger P
    Urol Res; 2004 Feb; 32(1):61-8. PubMed ID: 14628106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery.
    Asplin JR; Coe FL
    J Urol; 2007 Feb; 177(2):565-9. PubMed ID: 17222634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures.
    Suryavanshi MV; Bhute SS; Jadhav SD; Bhatia MS; Gune RP; Shouche YS
    Sci Rep; 2016 Oct; 6():34712. PubMed ID: 27708409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine oxalate levels in a New Zealand reference population and renal stone formers.
    Larking P; Lovell-Smith CJ; Hocken AG
    N Z Med J; 1983 Aug; 96(737):606-7. PubMed ID: 6575312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxaluria in urinary lithiasis].
    Thomas J; Charransol G; Barthelemy C; Thomas E; Legrand JC; Desgrez P; Steg A
    Presse Med; 1983 Sep; 12(32):1991-4. PubMed ID: 6225103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dietary intake on urinary oxalate excretion in calcium oxalate stone formers in their forties.
    Naya Y; Ito H; Masai M; Yamaguchi K
    Eur Urol; 2000 Feb; 37(2):140-4. PubMed ID: 10705190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxalate metabolism after intestinal bypass operations.
    Nordenvall B; Backman L; Larsson L
    Scand J Gastroenterol; 1981 Apr; 16(3):395-9. PubMed ID: 16435482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
    Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
    Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers.
    Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A
    Nephron; 1986; 43(3):234-5. PubMed ID: 3724934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.